Ca2+-sensitive inhibition by Pb2+ of α7-containing nicotinic acetylcholine receptors in hippocampal neurons

Brain Research

Volumn 873, Issue 1, 2000, Pages 112-123

  Mike, Arpad ^a   Pereira, Edna F R ^a   Albuquerque, Edson X ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Inst Cie Biomed Ctro Cie Da S   (Brazil)

Author keywords

Acetylcholine; Choline; Electrophysiology; Hippocampus; Lead; Nicotinic receptors

Indexed keywords

LEAD; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FETUS; HIPPOCAMPUS; IN VITRO STUDY; LEAD POISONING; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; CALCIUM; CELLS, CULTURED; ELECTROPHYSIOLOGY; HIPPOCAMPUS; LEAD; NEURAL INHIBITION; NEURONS; OSMOLAR CONCENTRATION; RATS; RECEPTORS, NICOTINIC; TIME FACTORS;

EID: 0034604821     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02533-6     Document Type: Article

References (38)

1. Albuquerque E.X., Alkondon M., Pereira E.F.R., Castro N.G., Schrattenholz A., Barbosa C.T.F., Bonfante-Cabarcas R., Aracava Y., Eisenberg H., Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J. Pharmacol. Exp. Ther. 280:1997;1117-1136.
2. Alkondon M., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: I Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther. 265:1993;1455-1473.
3. Alkondon M., Costa A.C., Radhakrishnan V., Aronstam R.S., Albuquerque E.X. Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett. 261:1990;124-130.
4. Audesirk G., Audesirk T. The effects of inorganic lead on voltage-sensitive calcium channels differs among cell types and among channel subtypes. NeuroToxicology. 14:1993;259-265.
5. Audesirk T., Audesirk G., Ferguson C., Shugarts D. Effects of inorganic lead on the differentiation and growth of cultured hippocampal and neuroblastoma cells. NeuroToxicology. 12:1991;529-538.
6. Banks E.C., Ferretti L.E., Shucard D.W. Effects of low level lead exposure on cognitive function in children: a review of behavioral, neuropsychological and biological evidence. NeuroToxicology. 18:1997;237-281.
7. Braga M.F.M., Pereira E.F.R., Marchioro M., Albuquerque E.X. Lead increases tetrodotoxin-insensitive spontaneous release of glutamate and GABA from hippocampal neurons. Brain Res. 826:1999;10-21.
8. Büsselberg D., Evans M.L., Rahmann H., Carpenter D.O. Lead and zinc block a voltage-activated calcium channel of Aplysia neurons. J. Neurophysiol. 65:1991;786-795.
9. Danscher G., Fjerdingstad E.J., Fjerdingstad E., Fredens K. Heavy metal content in subdivisions of the rat hippocampus (zinc, lead and copper). Brain Res. 112:1976;442-446.
10. Davis J.M., Elias R.W., Grant L.D. Current issues in human lead exposure and regulation of lead. NeuroToxicology. 14:1993;15-27.
11. Frederickson C.J. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol. 31:1989;145-238.
12. 2+ inhibits NMDA receptor function at high and low affinity sites: developmental and regional brain expression. NeuroToxicology. 18:1997;43-45.
13. 3H]MK-801 binding to the NMDA receptor-gated ionophore: in vitro and in vivo studies. Neurosci. Lett. 148:1992;27-30.
14. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflüg. Arch. 39:1981;85-100.
15. Hammond P.B., Dietrich D.N. Lead exposure in early life: health consequences. Rev. Environ. Contam. Toxicol. 115:1990;91-124.
16. 2+-ATPase activity by cadmium, lead and mercury. Enzyme. 45:1991;109-115.
17. Hunter B.E., de Fiebre C.M., Papke R.L., Kem W.R., Meyer E.M. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci. Lett. 168:1994;130-134.
18. Ishihara K., Alkondon M., Montes J.G., Albuquerque E.X. Ontogenically related properties of N-methyl-D-aspartate receptors in rat hippocampal neurons and the age-specific sensitivity of developing neurons to lead. J. Pharmacol. Exp. Ther. 273:1995;1459-1470.
19. Ishihara K., Alkondon M., Montes J.G., Albuquerque E.X. Nicotinic responses in acutely dissociated rat hippocampal neurons and the selective blockade of fast-desensitizing nicotinic currents by lead. J. Pharmacol. Exp. Ther. 273:1995;1471-1482.
20. Izquierdo I., Medina J.H. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol. Learn. Mem. 68:1997;285-316.
21. Krupp J.J., Vissel B., Heinemann S.F., Westbrook G.L. Calcium-dependent inactivation of recombinant N-methyl-D-aspartate receptors is NR2 subunit specific. Mol. Pharmacol. 50:1996;1680-1688.
22. Lasley S.M., Polan-Curtin J., Armstrong D.L. Chronic exposure to environmental levels of lead impairs in vivo induction of long-term potentiation in rat hippocampal dentate. Brain Res. 614:1993;347-351.
23. Levin E.D., Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berlin). 138:1998;217-230.
24. Marchioro M., Swanson K.L., Aracava Y., Albuquerque E.X. Glycine and calcium-dependent effects of lead on N-methyl-D-aspartate receptor function in rat hippocampal neurons. J. Pharmacol. Exp. Ther. 279:1996;143-153.
25. Mike A., Albuquerque E.X. A kinetic analysis of acetylcholine- and choline-activated α7-containing nicotinic receptor channels in hippocampal neurons. Proc. Mtg. Neuronal Nicotinic Receptors, Venice, Italy :1999;69.
26. Olden K. Environmental risks to the health of American children. Prev. Med. 22:1993;576-578.
27. Omelchenko I.A., Nelson C.S., Allen C.N. Lead inhibition of N-methyl-D-aspartate receptors containing NR2A, NR2C and NR2D subunits. J. Pharmacol. Exp. Ther. 282:1997;1458-1464.
28. Oortgiesen M., van Kleef R.G., Bajnath R.B., Vijverberg H.P. Nanomolar concentrations of lead selectively block neuronal nicotinic acetylcholine responses in mouse neuroblastoma cells. Toxicol. Appl. Pharmacol. 103:1990;165-174.
29. Ouyang H., Vogel H.J. Metal ion binding to calmodulin: NMR and fluorescence studies. Biometals. 11:1998;213-222.
30. Schwartz J. Societal benefits of reducing lead exposure. Environ. Res. 66:1994;105-124.
31. Simons T.J. Lead-calcium interactions in cellular lead toxicity. NeuroToxicology. 14:1993;77-85.
32. Stokes L., Letz R., Gerr F., Kolczak M., McNeill F.E., Chettle D.R., Kaye W.E. Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup. Environ. Med. 55:1998;507-516.
33. 2+ on protein kinase C isozymes. Toxicol. Appl. Pharmacol. 156:1999;40-45.
34. Swanson K.L., Marchioro M., Ishihara K., Alkondon M., Pereira E.F.R., Albuquerque E.X. Neuronal targets of lead in the hippocampus: relationship to low-level lead intoxication. Comp. Toxicol. 11:1997;471-493.
35. Ujihara H., Albuquerque E.X. Developmental change of the inhibition by lead of NMDA-activated currents in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 263:1992;868-875.
36. 2+ in the synaptic cleft. Biophys. J. 72:1997;2103-2116.
37. 2+)-dependent K+ channels. Cell. Mol. Neurobiol. 14:1994;841-857.
38. Winneke G., Lilienthal H., Krämer U. The neurobehavioural toxicology and teratology of lead. Arch. Toxicol. Suppl. 18:1996;57-70.